Search Results - "Robinson, William R."

A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609 Cohort 47) in patients with gestational trophoblastic neoplasia by Patel, Sandip P, Othus, Megan, Chae, Young Kwang, Dennis, Michael J, Gordon, Sarah, Mutch, David, Samlowski, Wolfram, Robinson, William R, Sharon, Elad, Ryan, Christopher, Lopez, Gabby, Plets, Melissa, Blanke, Charles, Kurzrock, Razelle

“…The efficacy of immune checkpoint blockade in gestational trophoblastic neoplasia (GTN) remains uncertain. We report the results of the GTN cohort of SWOG…”
Get full text

Does raising morning rectal temperature to evening levels offset the diurnal variation in muscle force production? by Edwards, Ben J, Pullinger, Samuel A, Kerry, Jonathan W, Robinson, William R, Reilly, Tom P, Robertson, Colin M, Waterhouse, James M

“…Muscle force production and power output in active males, regardless of the site of measurement (hand, leg, or back), are higher in the evening than in the…”
Get more information

Does lowering evening rectal temperature to morning levels offset the diurnal variation in muscle force production? by Robinson, William R, Pullinger, Samuel A, Kerry, Jonathan W, Giacomoni, Magali, Robertson, Colin M, Burniston, Jatin G, Waterhouse, James M, Edwards, Ben J

“…Muscle force production and power output in active males, regardless of the site of measurement (hand, leg, or back), are higher in the evening than the…”
Get more information

Impact of a Student-Run Clinic in a Non-Profit Substance Abuse Rehabilitation Facility for Women [32B] by Tran, Cassandra, Ngo, Lisa, Crowley, Michelle, Tran, Stacey, Robinson, William R

“…INTRODUCTION:Substance abuse is a growing problem among women, and is frequently accompanied by multiple gynecologic concerns. Residential substance abuse…”
Get full text

Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009 by Tiersten, Amy D, Liu, P.Y, Smith, Harriet O, Wilczynski, Sharon P, Robinson, William R, Markman, Maurie, Alberts, David S

“…Abstract Objective Intraperitoneal (IP) chemotherapy prolongs survival in optimally reduced ovarian cancer patients. For patients in whom optimal debulking…”
Get full text

Social support in cancer: How do patients want us to help? by Korotkin, Brittany D., Hoerger, Michael, Voorhees, Sara, Allen, Chynna O., Robinson, William R., Duberstein, Paul R.

“…Objective: Social support is fundamentally important to the well-being of patients with cancer, and informal caregivers often wish they had better insight into…”
Get full text

Circadian variation in muscle force output in males using isokinetic, isometric dynamometry: can we observe this in multi-joint movements using the muscleLab force-velocity encoder and are they similar in peak and magnitude? by Robertson, Colin M, Pullinger, Samuel A, Robinson, William R, Smith, Matt E, Burniston, Jatin G, Edwards, Ben J

“…We have investigated the magnitude of circadian variation in Isokinetic and Isometric strength of the knee extensors and flexors, as well as back squat and…”
Get more information

Distress among African American and White adults with cancer in Louisiana by Perry, Laura M., Hoerger, Michael, Sartor, Oliver, Robinson, William R.

“…Purpose/Objectives: Screening for distress is a key priority in cancer care, and African American patients may experience increased distress compared to White…”
Get full text

Neoadjuvant chemotherapy is rarely the easy way out by Robinson, William R

Get full text

We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies by Alvarez, Ronald D

Get full text

Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: a Southwest Oncology Group Study by Tiersten, Amy D, Moon, James, Smith, Harriet O, Wilczynski, Sharon P, Robinson, 3rd, William R, Markman, Maurie, Alberts, David S

“…In vitro testing of the activity of chemotherapeutic agents has been suggested as 1 method to optimally select drugs for patients with ovarian cancer. There…”
Get more information

Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study by Hess, Lisa M, Huang, Helen Q, Hanlon, Alexandra L, Robinson, William R, Johnson, Rhonda, Chambers, Setsuko K, Mannel, Robert S, Puls, Larry, Davidson, Susan A, Method, Michael, Lele, Shashikant, Havrilesky, Laura, Nelson, Tina, Alberts, David S

“…Abstract Objectives Changes in cognitive function have been identified in and reported by many cancer survivors. These changes have the potential to impact…”
Get full text

The Impact of Molecular Testing and Therapy for Gynecologic Cancers in Low Resource Environments [31D] by Berger, Marisa C, Sartor, Rita A, Le, Anna H, Mahlum, Leigh S, Robinson, William R

“…INTRODUCTION:Targeted cancer therapies based on tumor molecular analysis have grown exponentially in the last 5 years. Multiple gynecologic tumors can express…”
Get full text

Recombinant human erythropoietin as an adjunct to radiation therapy and cisplatin for stage IIB–IVA carcinoma of the cervix: a Southwest Oncology Group study by Lavey, Robert S., Liu, P.Y., Greer, Benjamin E., Robinson, William R., Chang, Pui C., Wynn, Raymond B., Conrad, Marcel E., Jiang, Caroline, Markman, Maurie, Alberts, David S.

“…The survival of cervix cancer patients is associated with their hemoglobin (Hgb) level during radiotherapy. The Southwest Oncology Group (SWOG) conducted a…”
Get full text

Safety and efficacy of COVID‐19 convalescent plasma in severe pulmonary disease: A report of 17 patients by Pal, Priya, Ibrahim, Moayed, Niu, Alex, Zwezdaryk, Kevin J., Tatje, Elise, Robinson, William R., Ko, Leta, Satyavarapu, Ishwarya, Jones, Wallace E., Nachabe, Adeem, Luk, Alfred, Mushatt, David M., Halvorson, Karin, Denson, Joshua L., Smith, Charles C., Simeone, Francesco, Davis, Gaynelle, Gill, Sukhmani K., McDougal, April, Vigh, Aniko S., Peterson, Tim G., Ning, Bo, Hu, Tony, Socola, Francisco, Robinson, James, Safah, Hana, Saba, Nakhle S.

Get full text

An Inventory for Alternate Conceptions among First-Semester General Chemistry Students by Mulford, Douglas R, Robinson, William R

“…This manuscript (i) presents the Chemical Concepts Inventory (CCI), an inventory that faculty can use to judge for themselves the extent of several common…”
Get full text

Extraperitoneal metastases from recurrent ovarian cancer by Robinson, William R, Beyer, Julie, Griffin, Stephen, Kanjanavaikoon, Paiyarut

“…To identify patterns of metastasis in patients with recurrent ovarian cancer. The influence of the route of chemotherapy administration and sequence of agents…”
Get more information

Factors affecting the completion of intraperitoneal chemotherapy in women with ovarian cancer by Robinson, William R, Beyer, Julie

“…The use of intraperitoneal (IP) chemotherapy as treatment for ovarian cancer has been demonstrated to result in improved survival. However, it is associated…”
Get more information

Detection of Residual Subclinical Ovarian Carcinoma after Completion of Adjuvant Chemotherapy by NOURIANI, Mory, BAHADOR, Afshin, LENTZ, Scott E, PERSON, Richard T, ROBINSON, William R, RODRIGUEZ, Mildred, ROMAN, Lynda D, YU, Mimi C, ZEMPOLICH, Karen, DUBEAU, Louis, BEREK, Jonathan S, CHENG, Joan P, CHI, Dennis S, CLIBY, William A, DEL PRIORE, Giuseppe, DODSON, Mark K, DUGGAN, Bridgette D, GERSHENSON, David M

“…Purpose: We sought to test the hypothesis that the presence of telomerase activity in peritoneal washings of patients treated for ovarian carcinoma is a…”
Get full text

What would you do? by Robinson, William R

Get full text